Surgery with heated chemotherapy for thymus cancer spread to the chest
Part of Blood & lymphatic, Cancer clinical trials.
This trial combines surgery (burning away the tumor) with heated chemotherapy given directly into the chest to treat thymus gland tumors that have spread to the lining of the lung or chest wall. The goal is to remove the visible tumor and wash the area with heated chemo to help delay or prevent it from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of thymus gland tumor (thymoma or thymic carcinoma) confirmed by biopsy.
- The tumor must have spread to the lining of your chest or lung (pleura), or come back there after treatment.
- You must be between 16 and 80 years old.
- You should be in generally good health (with no major heart, lung, or other organ problems) and able to care for yourself.
- Any prior chemotherapy, radiation, or immunotherapy must have been finished at least 4–6 weeks before joining.
- You cannot have had any other cancer, severe medical conditions, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests giving chemotherapy directly into the chest (intrathoracic) during or after surgery to remove pleura tumors in people with thymoma or thymic cancer. It aims to see if this approach can reduce the chance of the cancer coming back.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
This trial studies PT-112, a new treatment, in people with thymoma or thymic carcinoma that has grown despite at least one prior platinum chemotherapy treatment. It may help shrink tumors or slow disease progression, especially when surgery is not possible.
This trial tests whether adding an immunotherapy drug called adebrelimab to chemotherapy and radiation before surgery can help shrink thymic cancer and improve outcomes. It is for people with locally advanced thymic carcinoma that can potentially be removed with surgery.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.